TRAF2 and neoplasm: illustrated that deletion of TNF receptor-associated factor 2 (TRAF2) redirected TNF signaling pathway to promote RIPK1-dependent apoptosis, thereby lowering TNF cytotoxicity threshold in tumor cells.